Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Synthesis Capital is a venture capital firm focused on early-stage investments in the Asia-Pacific region. Founded to transform global healthcare through technology, it specializes in sectors like healthcare, biotech, and climate. The firm targets innovations that improve health outcomes and wellbeing.
Synthesis Capital invests in pre-seed to Series A+ stages, targeting health and wellbeing technologies, interventions for the first 1000 days of life, and climate change adaptation. Check sizes are not specified, but the firm emphasizes supporting innovations that enhance physical and mental health.
Synthesis Capital has partnered with MedTech Actuator, which provides access to a diverse pool of investment-ready startups and a supportive ecosystem for venture development.
Submit through their form at synthesiscapital.vc.
Synthesis Capital primarily invests in healthcare, biotech, digital health, longevity, and climate sectors.
The firm invests in pre-seed, seed, Series A, and Series A+ (extension) stages.
Synthesis Capital provides access to a network of resources and partnerships, particularly through its collaboration with the MedTech Actuator.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.